Tumor morphology was evaluated by a veterinary pathologist with experience in mouse sarcoma models, and skeletal muscle differentiation was evaluated using phosphotungstic acid–Hematoxylin (PTAH) histochemical staining and immunohistochemistry for desmin and myogenin, markers of muscle and skeletal muscle differentiation (Fig. 2A-D). This evidence concerns the gene DES and sarcoma.